IIM
XFOR icon

INTECH Investment Management’s X4 Pharmaceuticals XFOR Stock Holding History

INTECH Investment Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.7K Buy
+17,290
New +$70.9K ﹤0.01% 1982
2025
Q2 		– Sell
-1,932
Closed -$13.7K – 2686
2025
Q1 		$13.7K Buy
+1,932
New +$26.6K ﹤0.01% 2513

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's XFOR Position: Q2 2026 in Review

INTECH Investment Management opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 17,290 shares worth $80.7K. The stake represents ﹤0.01% of the portfolio and ranks #1982 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in XFOR as recently as Q1 2025.

INTECH Investment Management first reported a position in XFOR in Q1 2025 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • INTECH Investment Management held 17,290 shares of X4 Pharmaceuticals worth $80.7K as of Q2 2026.
  • X4 Pharmaceuticals was a new INTECH Investment Management position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1982 holding.
  • INTECH Investment Management first reported a position in X4 Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.